ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SCLP Scancell Holdings Plc

9.60
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.60 9.40 9.80 9.60 9.60 9.60 114,837 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.44 89.07M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9.60p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £89.07 million. Scancell has a price to earnings ratio (PE ratio) of -7.44.

Scancell Share Discussion Threads

Showing 13726 to 13745 of 65900 messages
Chat Pages: Latest  560  559  558  557  556  555  554  553  552  551  550  549  Older
DateSubjectAuthorDiscuss
15/2/2018
20:42
New Hardman report:-
miavoce
15/2/2018
18:20
Not that it really matters but when RG was asked about "which Moditope adjuvant" at the 2017-10 AGM and didn't say, the (possible) clue was in the 2017-09-13 CIMT poster abstracts pdf:

B007 / Conjugation of peptide vaccine directly to TLR agonists generates enhanced immune responses and tumor therapy
Brentville V, [snip] Durrant L, ... ISA Pharmaceuticals BV.

"These studies suggest that intradermal injection of citrullinated peptide linked directly to a Th1 polarising adjuvant such as TLR1/2 or TLR9 agonist should be considered for translation into the clinic."

Or am I just slow here having only just noticed?

djt59
15/2/2018
16:33
O N W -
Great Minds .... Guffaw

the real lozan
15/2/2018
16:29
J777J
I honestly don't think it will have a massive effect straight away.
The money is specifically for the " challenge ", none of it will flow directly to SCLP.

tosh 123
15/2/2018
16:28
J777J
Personally I think that the CRUK award has more to do with Prestige/PR/Cred as it won't take any development costs away from the company but will underline the Platforms' cred in a Global environment.
When you think about it it's more likely to become a negative for the share price if they DON'T get a substantial award... If they do , well it's what we all and the market now expects isn't it?
AIMO
ATB

oldnotwise
15/2/2018
16:18
Any thoughts on the share price if they win the £20 million grant from CRUK?


They are already collaborating so must have a fairly good chance of scooping the pot.

j777j
15/2/2018
16:16
As I said the other day, in my experience, if the BOD suddenly become active and are out there shouting about their company, it normally follows that a raising isnt too far behind.... Lets wait and see.
tosh 123
15/2/2018
16:14
Lozan,
normally I would agree with you 100%, and it does smack of a pump before a fund raise, especially with what we now know eg ;- £12 mill required within 6 months as well as the electricity money, but... I'm really hoping that our new CEO has taken note of our former CEO's numerous gaffs, and has decided to do things in an honourable manner.
RG lost a lot of respect from many people ( myself included ), I think that the new BOD are more than aware of this, and will conduct themselves accordingly.

But hey, who knows ?
Its just nice to see reasonable volume and a blue number... its been way too long !
Not sure whether the share price can continue the upward momentum for long, but lets enjoy it while it lasts.

tosh 123
15/2/2018
16:04
Loz , very noticeable in the Interview that the dreaded funding was not mentioned. I guess Cliff wanted to avoid that subject.
panama7
15/2/2018
15:55
PP S-
Anyone think this 'might' be being {a} 'set-up' for a 'fund-raising/ placing' ???

the real lozan
15/2/2018
15:53
P S -
Re = LULL
I will of course be happy to be proed WRONG.... for ONCE o / -

the real lozan
15/2/2018
13:32
Well fwiw - a small cohort for Phase I of the trial would prove up toxicity (or lack of hopefully) & on the back of that they may have agreement in principle.
gooosed
15/2/2018
13:25
Goosed, what’s your take on that? Purely down to funding or others input?
rhatton
15/2/2018
13:22
Significant scale back in SCIB1 Phase I/II trial . . . . .
gooosed
15/2/2018
10:37
Loz
Well, I should have written,"I,like you can only hope...."
Yes I know we were agreeing and the IP is the only thing we have ATM.... But a nice newly announced income stream / capital injection from a well negotiated licensing/collaborative agreement might change that... but who knows?
As I see it we're on a bed of hope ATM, lets hope we're not disappointed near term, but sadly that's still a possibility.
AIMO
ATB

oldnotwise
15/2/2018
10:30
O N W -
"I can only hope that we don't sell the family silver for peanuts, "
THAT was EXACTLY my point
SCLP don't have 'much else' to 'bargain with'.... other than 'the IP'

the real lozan
15/2/2018
10:25
I see the market is already reacting and 'taking-the-shine-off' the M F F F 'cheer-leaders' ... "We are MINTED"... "UP we GO"... 'CERTAINTY' version of S P movements
the real lozan
15/2/2018
10:24
Loz,
Agree the funding's the key now.
Sadly people don't seem to understand that the science became secondary to the commercialisation some years ago, and although the science continued to glitter, the financing didn't.
Now I'm with you, we're at a junction where the BOD's negotiations/acceptances/strategy will determine not only the future direction of the company but also the quality of the RONC on new money.
The manner in which the funding is achieved is also seriuosly important, and wouldn't it be interesting if we had to endure another two or three years of inaction if the purse strings were held tightly shut against any terms the BOD insisted on enforcing rather than "give away" the IP too cheaply? I doubt that but it's not impossible.
We have one trial funded already and that's a start.
What comes next is an unknown, but surely the BOD wouldn't have entered into a collaboration requiring capital if that hadn't been secured already at an attractive term? I hope not.
So again (always the same now) maybe wait and see. I can only hope that we don't sell the family silver for peanuts, but that's something that can't be controlled from our side!
In the BOD we trust?
AIMO
ATB

oldnotwise
15/2/2018
10:17
P7 -
post re Timescales ...Quite right
No one seems to have *clocked-it*
Nor has the mention today in RNS of 2019.... sunk-in

the real lozan
15/2/2018
10:03
Tosh
I'll leave you to a more in depth discussion with someone who knows about NIPT ;-)
ATB

oldnotwise
Chat Pages: Latest  560  559  558  557  556  555  554  553  552  551  550  549  Older

Your Recent History

Delayed Upgrade Clock